The Class I HDAC Inhibitor Valproic Acid Strongly Potentiates Gemcitabine Efficacy in Pancreatic Cancer by Immune System Activation

Amber Blaauboer, Peter M. van Koetsveld, Dana A.M. Mustafa, Jasper Dumas, Fadime Dogan, Suzanne van Zwienen, Casper H.J. van Eijck, Leo J. Hofland*

*Corresponding author for this work

Research output: Contribution to journal › Article › Academic › peer-review

10 Citations (Scopus)
37 Downloads (Pure)

Fingerprint

Dive into the research topics of 'The Class I HDAC Inhibitor Valproic Acid Strongly Potentiates Gemcitabine Efficacy in Pancreatic Cancer by Immune System Activation'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science